Literature DB >> 6614890

Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid.

S Bennett, R Wise, D Weston, J Dent.   

Abstract

A combination of 3 g of ticarcillin and 200 mg of clavulanic acid was administered intravenously to six healthy male volunteers, after which the concentrations of these agents in serum and blister fluid were measured. The ratio of the two drugs in serum varied from 15:1 (ticarcillin-clavulanic acid) at the time of administration to 28:1 at 30 min and 62:1 at 5 h after injection. Both agents penetrated blister fluid rapidly, the ratio being 33:1 at 1 h and 66:1 at 3 h. The elimination rates of these agents were different, but for each compound they were similar in serum and blister fluid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614890      PMCID: PMC184977          DOI: 10.1128/AAC.23.6.831

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 3.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

4.  Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.

Authors:  J W Paisley; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

6.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

7.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

  7 in total
  18 in total

1.  Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.

Authors:  F A Manian; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.

Authors:  F Tausk; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

3.  In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.

Authors:  M D Kitzis; B Ferré; A Coutrot; J F Acar; L Gutmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

4.  Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Authors:  Kevin M Watt; Christoph P Hornik; Stephen J Balevic; Gratias Mundakel; C Michael Cotten; Barrie Harper; Daniel K Benjamin; Ravinder Anand; Matthew Laughon; P Brian Smith; Michael Cohen-Wolkowiez
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

5.  Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.

Authors:  G L Jungbluth; D L Cooper; G D Doyle; G M Chudzik; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

6.  Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.

Authors:  R J Boon; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

7.  In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.

Authors:  A L Barry; L W Ayers; T L Gavan; E H Gerlach; R N Jones
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

8.  Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.

Authors:  L Mizen; G Woodnutt; I Kernutt; E J Catherall
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

9.  Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.

Authors:  D Adam; H D Heilmann; K Weismeier
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

10.  In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.